Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $23.52 and last traded at $23.00, with a volume of 50870 shares traded. The stock had previously closed at $23.04.
Wall Street Analyst Weigh In
Separately, JPMorgan Chase & Co. started coverage on shares of Ascentage Pharma Group International in a research report on Thursday, March 27th. They issued an “overweight” rating on the stock.
View Our Latest Stock Analysis on Ascentage Pharma Group International
Ascentage Pharma Group International Stock Performance
About Ascentage Pharma Group International
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Read More
- Five stocks we like better than Ascentage Pharma Group International
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What is a SEC Filing?
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Start Investing in Real Estate
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
